U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226466) titled 'Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer' on Nov. 06.
Brief Summary: This study investigates the effects of brain radiotherapy on cognitive function by evaluating plasma biomarkers and apolipoprotein E (APOE) genotype in patients with primary or metastatic brain tumors. Standard brain radiotherapy is known to impact cognitive outcomes, yet the underlying biological mechanisms remain unclear.
Study Start Date: March 01, 2026
Study Type: OBSERVATIONAL
Condition:
Brain Tumor Adult
Brain Metastases From Solid Tumors
Brain Tumor, Primary
Brain Tumor
Intervention:
PROCEDURE: Blood sample
Blood sample w...